Cognitive-Behavioral Therapy vs Risperidone for Augmenting Serotonin Reuptake Inhibitors in Obsessive-Compulsive Disorder: A Randomized Clinical Trial

IMPORTANCE: Obsessive-compulsive disorder (OCD) is one of the world’s most disabling illnesses according to the World Health Organization. Serotonin reuptake inhibitors (SRIs) are the only medications approved by the Food and Drug Administration to treat OCD, but few patients achieve minimal symptom...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Simpson, Helen Blair, Foa, Edna B., Liebowitz, Michael R., Huppert, Jonathan D., Cahill, Shawn, Maher, Michael J., McLean, Carmen P., Bender, James, Marcus, Sue M., Williams, Monnica T., Weaver, Jamie, Vermes, Donna, Van Meter, Page E., Rodriguez, Carolyn I., Powers, Mark, Pinto, Anthony, Imms, Patricia, Hahn, Chang-Gyu, Campeas, Raphael
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2013
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3955365/
https://ncbi.nlm.nih.gov/pubmed/24026523
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamapsychiatry.2013.1932
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak